# Sorrento Therapeutics Inc. (SRNE)

Source: https://www.quantisnow.com/company/SRNE
Generated: 2026-11-17T14:41:39.623Z

- Ticker: SRNE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Commercial Physical & Biological Resarch
- Website: sorrentotherapeutics.com

## About

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as bispecific antibody approaches; and Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host diseases. The company also develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. In addition, it engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; and SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain conditions. Additionally, the company has various collaborations with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 86 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patients with melanoma; and Karolinska Institutet. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California.

## Latest SRNE news and filings

- 2025-01-31 14:00 UTC [Dividends] [Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025](https://www.quantisnow.com/insight/scilex-holding-company-announces-that-the-us-bankruptcy-court-has-5864684)
- 2023-11-07 21:34 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-leadership-update-other-5066733)
- 2023-11-03 21:31 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5059863)
- 2023-10-05 21:26 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5007824)
- 2023-09-26 20:54 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Regulation FD Disclosure, Other Events](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4988821)
- 2023-09-13 01:51 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-other-events-financial-4967665)
- 2023-08-28 21:25 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4941438)
- 2023-08-21 15:20 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4921282)
- 2023-08-12 00:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sorrento-therapeutics-inc-4887747)
- 2023-08-10 20:14 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4878994)
- 2023-08-07 20:15 UTC [SEC Form NT 10-Q filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-sorrento-therapeutics-inc-4856387)
- 2023-08-01 10:01 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4822515)
- 2023-07-18 21:23 UTC [SEC Form POS AM filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-sorrento-therapeutics-inc-4767872)
- 2023-07-13 10:26 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4748964)
- 2023-07-08 01:49 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4733493)
- 2023-06-21 21:24 UTC [SEC Form POS AM filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-sorrento-therapeutics-inc-4669157)
- 2023-06-20 21:01 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4662776)
- 2023-06-15 13:41 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4645790)
- 2023-05-19 01:23 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4530055)
- 2023-05-15 19:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sorrento-therapeutics-inc-4505078)
- 2023-05-15 16:03 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4503396)
- 2023-05-12 21:28 UTC [SEC Form POS AM filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-sorrento-therapeutics-inc-4498128)
- 2023-05-09 01:04 UTC [SEC Form NT 10-Q filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-sorrento-therapeutics-inc-4465607)
- 2023-04-25 23:21 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4384421)
- 2023-04-20 21:26 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-other-events-financial-4363957)
- 2023-04-20 16:08 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-other-events-financial-4361572)
- 2023-04-10 21:22 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-other-events-financial-4318130)
- 2023-04-10 19:15 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-other-events-financial-4317077)
- 2023-03-31 01:39 UTC [SEC Form 8-K] [Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sorrento-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4276504)
- 2023-03-20 23:52 UTC [SEC Form 4] [SEC Form 4 filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-sorrento-therapeutics-inc-4226260)
- 2023-03-10 16:21 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Sorrento Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-sorrento-therapeutics-inc-amendment-4185705)
- 2023-03-01 01:35 UTC [SEC Form NT 10-K filed by Sorrento Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-sorrento-therapeutics-inc-4139521)
- 2023-02-22 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-4101095)
- 2023-02-22 18:10 UTC [Market Insight] [Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-quoin-pharmaceuticals-shares-are-trading-lower-by-over-40-4099239)
- 2023-02-22 14:37 UTC [Market Insight] [Gilead Sciences Touts Encouraging Data From Real World Studies Of Its Flagship COVID-19 Treatment](https://www.quantisnow.com/insight/gilead-sciences-touts-encouraging-data-from-real-world-studies-of-4097707)
- 2023-02-22 14:35 UTC [Market Insight] [Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing](https://www.quantisnow.com/insight/bankrupt-sorrento-therapeutics-secures-court-approval-for-75m-financing-4097701)
- 2023-02-22 13:55 UTC [Market Insight] [Why Sorrento Therapeutics Stock Is Soaring Today](https://www.quantisnow.com/insight/why-sorrento-therapeutics-stock-is-soaring-today-4097109)
- 2023-02-22 13:55 UTC [Market Chatter] [Sorrento Therapeutics shares are trading higher after the U.S. Bankruptcy Court granted interim approval of the company's $75 million debtor-in-possession financing.](https://www.quantisnow.com/insight/sorrento-therapeutics-shares-are-trading-higher-after-the-us-bankruptcy-4097107)
- 2023-02-22 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-4096736)
- 2023-02-22 13:02 UTC [Market Insight] [Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-wag-group-shares-are-trading-higher-by-around-22-4096698)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SRNE
- Earnings history: https://www.quantisnow.com/earnings/SRNE
- Dividend history: https://www.quantisnow.com/dividends/SRNE
- Insider transactions: https://www.quantisnow.com/insiders/SRNE
- Options chain: https://www.quantisnow.com/options/SRNE
- SEC 8-K filings only: https://www.quantisnow.com/company/SRNE/8-k
- RSS and alerts for SRNE: https://www.quantisnow.com/docs/rss-feeds.md
